Close

Ratings by H.C. Wainwright (Debjit Chattopadhyay)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/16/2024 Fate Therapeutics FATE Maintain Neutral
(N/A)
 
 
  Details
5/16/2024 Allogene ALLO Maintain Buy
(N/A)
 
 
  Details
5/13/2024 MacroGenics MGNX Maintain Neutral
(N/A)
 
 
  Details
3/11/2024 MacroGenics MGNX Maintain Neutral
(N/A)
 
 
  Details
3/7/2024 WAVE Life Sciences WVE Maintain Buy
(N/A)
 
 
  Details
2/21/2024 Bicycle Therapeutics BCYC Maintain Buy
(N/A)
 
 
  Details
2/14/2024 MacroGenics MGNX Downgrade Neutral
(Buy)
17.35
(4.37)
-74.81% Details
1/19/2024 Allogene ALLO Maintain Buy
(N/A)
 
 
  Details
12/13/2023 Harpoon Therapeutics HARP Maintain Buy
(N/A)
 
 
  Details
11/30/2023 Immunogen Inc. IMGN Downgrade Neutral
(Buy)
16.06
(31.25)
94.58% Details
11/15/2023 Allogene ALLO Maintain Buy
(N/A)
 
 
  Details
11/13/2023 MacroGenics MGNX Maintain Buy
(N/A)
 
 
  Details
11/3/2023 Immunogen Inc. IMGN Maintain Buy
(N/A)
 
 
  Details
9/14/2023 Harpoon Therapeutics HARP Maintain Buy
(N/A)
 
 
  Details
8/29/2023 Immunogen Inc. IMGN Maintain Buy
(N/A)
 
 
  Details
8/1/2023 Immunogen Inc. IMGN Maintain Buy
(N/A)
 
 
  Details
6/13/2023 Immunogen Inc. IMGN Maintain Buy
(N/A)
 
 
  Details
4/4/2023 Allogene ALLO Maintain Buy
(N/A)
 
 
  Details
3/29/2023 Harpoon Therapeutics HARP Maintain Buy
(N/A)
 
 
  Details
3/20/2023 MacroGenics MGNX Maintain Buy
(N/A)
 
 
  Details
1/24/2023 Fate Therapeutics FATE Downgrade Neutral
(Buy)
5.55
(3.90)
-29.73% Details
12/30/2022 Immunogen Inc. IMGN Maintain Buy
(N/A)
 
 
  Details
12/5/2022 Stoke Therapeutics STOK Maintain Buy
(N/A)
 
 
  Details
11/21/2022 Allogene ALLO Maintain Buy
(N/A)
 
 
  Details
11/16/2022 Immunogen Inc. IMGN Maintain Buy
(N/A)
 
 
  Details
11/7/2022 MacroGenics MGNX Maintain Buy
(N/A)
 
 
  Details
10/18/2022 MacroGenics MGNX Maintain Buy
(N/A)
 
 
  Details
9/12/2022 MacroGenics MGNX Maintain Buy
(N/A)
 
 
  Details
8/15/2022 Harpoon Therapeutics HARP Maintain Buy
(N/A)
 
 
  Details
8/5/2022 Bicycle Therapeutics BCYC Maintain Buy
(N/A)
 
 
  Details
8/5/2022 Jounce Therapeutics JNCE Maintain Buy
(N/A)
 
 
  Details
3/4/2022 Fate Therapeutics FATE Maintain Buy
(N/A)
 
 
  Details
6/7/2021 Fate Therapeutics FATE Upgrade Buy
(Neutral)
72.79
(3.90)
-94.64% Details
3/30/2021 WAVE Life Sciences WVE Maintain Buy
(N/A)
 
 
  Details
12/4/2020 Jounce Therapeutics JNCE New Coverage Buy
(N/A)
6.89
(1.88)
-72.71% Details
8/24/2020 Galapagos NV GLPG Downgrade Neutral
(Buy)
137.16
(29.63)
-78.4% Details
6/26/2020 uniQure BV QURE Maintain Buy
(N/A)
 
 
  Details
6/12/2020 Allogene ALLO Maintain Buy
(N/A)
 
 
  Details
5/29/2020 Allogene ALLO Maintain Buy
(N/A)
 
 
  Details
5/26/2020 MacroGenics MGNX Maintain Buy
(N/A)
 
 
  Details
5/18/2020 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
5/14/2020 Allogene ALLO Maintain Buy
(N/A)
 
 
  Details
5/13/2020 Sutro Biopharma STRO Maintain Buy
(N/A)
 
 
  Details
5/13/2020 Fate Therapeutics FATE New Coverage Buy
(N/A)
28.75
(3.90)
-86.43% Details
5/12/2020 Nektar Therapeutics NKTR Maintain Neutral
(N/A)
 
 
  Details
4/17/2020 Bicycle Therapeutics BCYC New Coverage Buy
(N/A)
14.62
(21.36)
46.1% Details
3/13/2020 Allogene ALLO New Coverage Buy
(N/A)
21.07
(2.77)
-86.85% Details
3/11/2020 Precision BioSciences Inc. DTIL Maintain Buy
(N/A)
 
 
  Details
3/4/2020 Voyager Therapeutics VYGR Maintain Buy
(N/A)
 
 
  Details
3/3/2020 Zymeworks ZYME Maintain Buy
(N/A)
 
 
  Details
2/24/2020 Galapagos NV GLPG Maintain Buy
(N/A)
 
 
  Details
2/3/2020 Harpoon Therapeutics HARP New Coverage Buy
(N/A)
13.29
(23.01)
73.14% Details
1/2/2020 WAVE Life Sciences WVE Maintain Buy
(N/A)
 
 
  Details
12/17/2019 Immunogen Inc. IMGN Maintain Buy
(N/A)
 
 
  Details
12/10/2019 Synothorx Inc. THOR Downgrade Neutral
(Buy)
67.71
(67.99)
0.41% Details
12/3/2019 Audentes Therapeutics BOLD Downgrade Neutral
(Buy)
28.61
(9.67)
-66.2% Details
11/25/2019 Zymeworks ZYME New Coverage Buy
(N/A)
42.00
(9.12)
-78.29% Details
10/25/2019 Stoke Therapeutics STOK New Coverage Buy
(N/A)
22.86
(13.90)
-39.2% Details
8/20/2019 Sarepta Therapeutics SRPT Maintain Buy
(N/A)
 
 
  Details
8/12/2019 AUTL AUTL Maintain Buy
(N/A)
 
 
  Details
7/16/2019 Precision BioSciences Inc. DTIL New Coverage Buy
(N/A)
13.47
(12.40)
-7.94% Details
7/15/2019 Galapagos NV GLPG Maintain Buy
(N/A)
 
 
  Details
6/25/2019 Global Blood Therapeutics GBT Maintain Buy
(N/A)
 
 
  Details
6/17/2019 Amicus Therapeutics FOLD New Coverage Buy
(N/A)
11.66
(9.57)
-17.92% Details
5/6/2019 Immunogen Inc. IMGN Upgrade Buy
(Neutral)
2.88
(31.25)
985.07% Details
3/28/2019 Galapagos NV GLPG New Coverage Buy
(N/A)
95.62
(29.63)
-69.01% Details
3/18/2019 Audentes Therapeutics BOLD Maintain Buy
(N/A)
 
 
  Details
3/11/2019 Mersana MRSN Maintain Buy
(N/A)
 
 
  Details
3/4/2019 Immunogen Inc. IMGN Downgrade Neutral
(Buy)
2.51
(2.88)
14.74% Details
2/20/2019 Homology Medicines FIXX New Coverage Buy
(N/A)
24.03
(0.93)
-96.13% Details
2/6/2019 MacroGenics MGNX Maintain Buy
(N/A)
 
 
  Details
1/2/2019 Synothorx Inc. THOR New Coverage Buy
(N/A)
17.38
(67.71)
289.59% Details
12/4/2018 Global Blood Therapeutics GBT Maintain Buy
(N/A)
 
 
  Details
12/3/2018 Global Blood Therapeutics GBT Maintain Buy
(N/A)
 
 
  Details
11/26/2018 uniQure BV QURE Maintain Buy
(N/A)
 
 
  Details
10/24/2018 AUTL AUTL New Coverage Buy
(N/A)
32.80
(4.39)
-86.62% Details
10/2/2018 Avrobio Inc. AVRO Maintain Buy
(Buy)
 
 
  Details
9/24/2018 uniQure BV QURE Maintain Buy
(N/A)
 
 
  Details
9/18/2018 Mersana MRSN Maintain
(Neutral)
 
 
  Details
9/17/2018 Avrobio Inc. AVRo New Coverage Buy
(N/A)
36.73
(16.53)
-55% Details
8/13/2018 Jounce Therapeutics JNCE Maintain Buy
(N/A)
 
 
  Details